Ignite Creation Date:
2025-12-24 @ 11:57 PM
Ignite Modification Date:
2026-01-02 @ 5:20 PM
Study NCT ID:
NCT04317651
Status:
UNKNOWN
Last Update Posted:
2020-03-25
First Post:
2020-03-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Crizotinib in ALK Rearranged Non-small-cell Lung Cancer
Sponsor:
Fondazione Ricerca Traslazionale
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
SPECIALK
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None